Avanzanite Bioscience
PrivateLast Round
Series A
Nov 18, 2025
Total Funding Raised
$37.1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Avanzanite Bioscience is a specialty pharmaceutical company that provides a commercialization and distribution platform for biopharmaceutical partners to launch medicines for rare diseases across Europe.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Compliance
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avanzanite Bioscience Comparables
Compare Avanzanite Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ExCEEd Orphan | 85% | |
| Immedica Pharma | 84% | |
| Vector Pharma | 79% |
Avanzanite Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 18, 2025 |
Key People
Founding team and executive leadership
Avanzanite Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MVM Life Science Partners LLP | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 3, 2026
Grew 15% QoQ, from 78 to 90 employees.
- Jun 27, 2026
Grew 17% QoQ, from 72 to 84 employees.
Avanzanite Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Avanzanite Bioscience's valuation, stock price, and market status.
Is Avanzanite Bioscience a public or private company?
Avanzanite Bioscience is a private company.
What is the current stock price of Avanzanite Bioscience?
Avanzanite Bioscience is a private company with no public stock price. No recent secondary market data is available.
How much is Avanzanite Bioscience worth (valuation)?
Valuation information for Avanzanite Bioscience is not publicly available.
Can I buy Avanzanite Bioscience stock?
Avanzanite Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Avanzanite Bioscience's last funding round?
Avanzanite Bioscience's most recent funding round was Series A on November 18, 2025.
Who are the main investors in Avanzanite Bioscience?
Key investors in Avanzanite Bioscience include MVM Life Science Partners LLP.
Will Avanzanite Bioscience IPO soon?
No public IPO plans have been announced for Avanzanite Bioscience.
How can I track Avanzanite Bioscience secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Avanzanite Bioscience's secondary market activity and sign up for updates.